BIOREGENX, INC. (BRGX)

Every figure this model derived for BRGX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 9,057 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 45,806 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-03-31
current assets 190,292 AssetsCurrent 2026-03-31
current liabilities 3,987,822 LiabilitiesCurrent 2026-03-31
equity -4,533,316 StockholdersEquity 2026-03-31
interest expense 302,425 InterestExpense 2026-03-31
ocf 27,906 NetCashProvidedByUsedInOperatingActivities 2026-03-31
revenue 1,765,541 Revenues 2026-03-31
sbc 6,782 ShareBasedCompensation 2026-03-31

The ratios

The figures themselves rather than their scores — what somebody looking up BRGX on one particular measure came for.

RatioValue
cash operating margin-57.73
current ratio0.05
current ratio reported0.05
deferred revenue growth-70.14
dilution pct5.19
fcf margin1.07
growth cv1.77
interest cover-3.64
operating margin-62.37
owner earnings margin0.68
revenue growth-23.43
revenue growth per share-27.21
rule of 40-85.8
sbc pct revenue0.38

What to be careful about

What this model itself distrusts about BRGX's figures. Written by the derivation as it ran, not added afterwards.